Publication Information

{'id': 'https://openalex.org/W2084076223', 'doi': 'https://doi.org/10.1586/14787210.2014.942282', 'title': 'Efficacy of daclatasvir in hepatitis C virus', 'display_name': 'Efficacy of daclatasvir in hepatitis C virus', 'publication_year': 2014, 'publication_date': '2014-07-25', 'ids': {'openalex': 'https://openalex.org/W2084076223', 'doi': 'https://doi.org/10.1586/14787210.2014.942282', 'mag': '2084076223', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/25059552'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1586/14787210.2014.942282', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S185628608', 'display_name': 'Expert Review of Anti-infective Therapy', 'issn_l': '1478-7210', 'issn': ['1478-7210', '1744-8336'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5066924600', 'display_name': 'Namiki Izumi', 'orcid': 'https://orcid.org/0000-0002-0055-8229'}, 'institutions': [{'id': 'https://openalex.org/I4210149722', 'display_name': 'Musashino Red Cross Hospital', 'ror': 'https://ror.org/05bz4s011', 'country_code': 'JP', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2799517759', 'https://openalex.org/I4210149722']}], 'countries': ['JP'], 'is_corresponding': True, 'raw_author_name': 'Namiki Izumi', 'raw_affiliation_strings': ['Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Kyonancho 1-26-1, Musashinoshi, Tokyo, 1808610 Japan.'], 'affiliations': [{'raw_affiliation_string': 'Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Kyonancho 1-26-1, Musashinoshi, Tokyo, 1808610 Japan.', 'institution_ids': ['https://openalex.org/I4210149722']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5066924600'], 'corresponding_institution_ids': ['https://openalex.org/I4210149722'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.301, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 11, 'citation_normalized_percentile': {'value': 0.277076, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 86, 'max': 87}, 'biblio': {'volume': '12', 'issue': '9', 'first_page': '1025', 'last_page': '1031'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10151', 'display_name': 'Hepatitis C virus research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2721', 'display_name': 'Hepatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10151', 'display_name': 'Hepatitis C virus research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2721', 'display_name': 'Hepatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10308', 'display_name': 'Systemic Lupus Erythematosus Research', 'score': 0.9919, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11016', 'display_name': 'Monoclonal and Polyclonal Antibodies Research', 'score': 0.9907, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/daclatasvir', 'display_name': 'Daclatasvir', 'score': 0.9989461}, {'id': 'https://openalex.org/keywords/ns5a', 'display_name': 'NS5A', 'score': 0.86640847}, {'id': 'https://openalex.org/keywords/regimen', 'display_name': 'Regimen', 'score': 0.4587311}, {'id': 'https://openalex.org/keywords/sofosbuvir', 'display_name': 'Sofosbuvir', 'score': 0.4547649}], 'concepts': [{'id': 'https://openalex.org/C2776979040', 'wikidata': 'https://www.wikidata.org/wiki/Q5207712', 'display_name': 'Daclatasvir', 'level': 5, 'score': 0.9989461}, {'id': 'https://openalex.org/C2777103181', 'wikidata': 'https://www.wikidata.org/wiki/Q83141840', 'display_name': 'NS5A', 'level': 5, 'score': 0.86640847}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.7262093}, {'id': 'https://openalex.org/C2780040827', 'wikidata': 'https://www.wikidata.org/wiki/Q421862', 'display_name': 'Ribavirin', 'level': 4, 'score': 0.6308908}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5950025}, {'id': 'https://openalex.org/C2776408679', 'wikidata': 'https://www.wikidata.org/wiki/Q708693', 'display_name': 'Hepatitis C virus', 'level': 3, 'score': 0.5737381}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.5374667}, {'id': 'https://openalex.org/C135763542', 'wikidata': 'https://www.wikidata.org/wiki/Q106016', 'display_name': 'Genotype', 'level': 3, 'score': 0.49559462}, {'id': 'https://openalex.org/C2781413609', 'wikidata': 'https://www.wikidata.org/wiki/Q7308373', 'display_name': 'Regimen', 'level': 2, 'score': 0.4587311}, {'id': 'https://openalex.org/C2778390639', 'wikidata': 'https://www.wikidata.org/wiki/Q2502747', 'display_name': 'Sofosbuvir', 'level': 5, 'score': 0.4547649}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.44907975}, {'id': 'https://openalex.org/C2781463415', 'wikidata': 'https://www.wikidata.org/wiki/Q2082778', 'display_name': 'Hepacivirus', 'level': 4, 'score': 0.30515373}, {'id': 'https://openalex.org/C2522874641', 'wikidata': 'https://www.wikidata.org/wiki/Q808', 'display_name': 'Virus', 'level': 2, 'score': 0.30033523}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.12999889}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.05137843}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.049371094}], 'mesh': [{'descriptor_ui': 'D000998', 'descriptor_name': 'Antiviral Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D016174', 'descriptor_name': 'Hepacivirus', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D006526', 'descriptor_name': 'Hepatitis C', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D007093', 'descriptor_name': 'Imidazoles', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000998', 'descriptor_name': 'Antiviral Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000998', 'descriptor_name': 'Antiviral Agents', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D002219', 'descriptor_name': 'Carbamates', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002986', 'descriptor_name': 'Clinical Trials as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D024882', 'descriptor_name': 'Drug Resistance, Viral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004359', 'descriptor_name': 'Drug Therapy, Combination', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016174', 'descriptor_name': 'Hepacivirus', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D016174', 'descriptor_name': 'Hepacivirus', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D016174', 'descriptor_name': 'Hepacivirus', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006526', 'descriptor_name': 'Hepatitis C', 'qualifier_ui': 'Q000821', 'qualifier_name': 'virology', 'is_major_topic': False}, {'descriptor_ui': 'D006526', 'descriptor_name': 'Hepatitis C', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007093', 'descriptor_name': 'Imidazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007093', 'descriptor_name': 'Imidazoles', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D016898', 'descriptor_name': 'Interferon-alpha', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016898', 'descriptor_name': 'Interferon-alpha', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D016898', 'descriptor_name': 'Interferon-alpha', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D011092', 'descriptor_name': 'Polyethylene Glycols', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011092', 'descriptor_name': 'Polyethylene Glycols', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D011092', 'descriptor_name': 'Polyethylene Glycols', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D011759', 'descriptor_name': 'Pyrrolidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012367', 'descriptor_name': 'RNA, Viral', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D012367', 'descriptor_name': 'RNA, Viral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011994', 'descriptor_name': 'Recombinant Proteins', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D011994', 'descriptor_name': 'Recombinant Proteins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011994', 'descriptor_name': 'Recombinant Proteins', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D012254', 'descriptor_name': 'Ribavirin', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D012254', 'descriptor_name': 'Ribavirin', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D012254', 'descriptor_name': 'Ribavirin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014633', 'descriptor_name': 'Valine', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': False}, {'descriptor_ui': 'D014633', 'descriptor_name': 'Valine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017361', 'descriptor_name': 'Viral Nonstructural Proteins', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D017361', 'descriptor_name': 'Viral Nonstructural Proteins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1586/14787210.2014.942282', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S185628608', 'display_name': 'Expert Review of Anti-infective Therapy', 'issn_l': '1478-7210', 'issn': ['1478-7210', '1744-8336'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/25059552', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.86, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 32, 'referenced_works': ['https://openalex.org/W1551301313', 'https://openalex.org/W1816714358', 'https://openalex.org/W1963756548', 'https://openalex.org/W1972821220', 'https://openalex.org/W1980771473', 'https://openalex.org/W1983154697', 'https://openalex.org/W1983369983', 'https://openalex.org/W1995591620', 'https://openalex.org/W1997249384', 'https://openalex.org/W1998593536', 'https://openalex.org/W2000988408', 'https://openalex.org/W2009780339', 'https://openalex.org/W2013010588', 'https://openalex.org/W2019915078', 'https://openalex.org/W2027545702', 'https://openalex.org/W2040361953', 'https://openalex.org/W2043976325', 'https://openalex.org/W2047911275', 'https://openalex.org/W2055540046', 'https://openalex.org/W2066172848', 'https://openalex.org/W2069338867', 'https://openalex.org/W2084798867', 'https://openalex.org/W2088053309', 'https://openalex.org/W2088596257', 'https://openalex.org/W2106172816', 'https://openalex.org/W2113864802', 'https://openalex.org/W2117801610', 'https://openalex.org/W2125963799', 'https://openalex.org/W2127685726', 'https://openalex.org/W2143559032', 'https://openalex.org/W2152320056', 'https://openalex.org/W2317872626'], 'related_works': ['https://openalex.org/W3031498534', 'https://openalex.org/W2982696294', 'https://openalex.org/W2953494464', 'https://openalex.org/W2807126090', 'https://openalex.org/W2786448332', 'https://openalex.org/W2560876434', 'https://openalex.org/W2460376027', 'https://openalex.org/W2172454869', 'https://openalex.org/W1980771473', 'https://openalex.org/W1181639237'], 'abstract_inverted_index': {'AbstractDaclatasvir': [0], 'is': [1, 138, 218, 266, 342], 'a': [2, 159, 186, 219, 239, 284, 296], 'novel': [3], 'NS5A': [4, 221, 321, 413], 'inhibitor': [5, 224, 322, 326], 'of': [6, 33, 40, 57, 61, 165, 214, 235, 315, 405], 'hepatitis': [7, 147, 245], 'C': [8, 246], 'virus': [9, 247], '(HCV).': [10], 'Daclatasvir': [11], 'combined': [12], 'with': [13, 22, 77, 180, 185, 193, 225, 254, 279, 305, 337, 371, 398], 'peginterferon': [14], 'α-2a': [15], 'and': [16, 44, 53, 59, 69, 87, 102, 111, 123, 168, 232, 241, 262, 281, 313, 323, 362, 385], 'ribavirin': [17, 263], 'in': [18, 31, 55, 189, 200, 211, 230, 244, 250, 268, 272, 295, 300, 360, 396], 'Japanese': [19, 163], 'patients': [20, 76, 251, 304, 368], 'infected': [21, 253], 'genotype': [23, 45, 78, 114, 256, 346, 358, 366], '1b': [24, 347], 'HCV': [25, 255], 'achieved': [26, 50], 'sustained': [27, 285], 'virological': [28, 81, 286], 'response': [29, 258, 287], '(SVR)': [30, 288], '100%': [32], 'treatment-naïve': [34], 'patients,': [35, 348], 'due': [36], 'to': [37, 72, 121, 140, 293, 318, 379, 412], 'high': [38, 382], 'rates': [39], 'favorable': [41], 'IL28B': [42], 'allele': [43], '1b.': [46], 'SVR': [47, 312, 374, 402], '24': [48, 289, 375], 'was': [49, 156, 209, 327, 354, 377], 'by': [51, 83, 94, 158, 260], 'asunaprevir': [52, 112, 282, 341], 'daclatasvir': [54, 110, 265, 280, 338], '87.4%': [56], 'intolerant': [58], '80.5%': [60], 'nonresponder': [62], 'patients.': [63], 'Baseline': [64], 'NS5A-resistant': [65, 125], 'variants': [66, 126, 331, 411], 'were': [67, 369], 'detected': [68], 'they': [70, 408, 415], 'failed': [71], 'achieve': [73, 311], 'SVR.': [74], 'Most': [75], '1a': [79, 359, 367], 'experienced': [80], 'breakthrough': [82], 'dual': [84, 275, 351, 387], 'oral': [85, 96, 276, 388], 'treatment,': [86], 'should': [88, 118, 127, 332, 390, 416], 'be': [89, 119, 128, 333, 380, 391], 'treated': [90, 259, 370], 'QUAD': [91], 'or': [92, 177, 183, 190, 197], 'replaced': [93], 'all': [95], 'regimens': [97, 108], 'that': [98], 'are': [99], 'more': [100, 420], 'potent': [101, 226, 421], 'have': [103, 172, 409], 'fewer': [104], 'side': [105], 'effects.': [106], 'IFN-free': [107], 'including': [109], 'for': [113, 344, 357, 393], '1': [115, 149], 'null': [116], 'responders': [117], 'tailored': [120, 392], 'subtype,': [122], 'preexisting': [124, 306], 'evaluated': [129], 'carefully': [130, 334], 'before': [131], 'choosing': [132], 'the': [133, 162, 194, 201, 212, 320, 324, 350, 363, 373, 386, 394], 'drugs.': [134], 'This': [135], 'regimen': [136, 389], 'alone': [137], 'unlikely': [139], 'move': [141], 'forward': [142], 'without': [143], 'additional': [144], 'agents.Keywords::': [145], 'asunaprevirchronic': [146], 'CDAAdaclatasvirgenotype': [148], 'Financial': [150], '&': [151], 'competing': [152], 'interests': [153], 'disclosureThis': [154], 'work': [155], 'supported': [157], 'Grant-in-aid': [160], 'from': [161, 204, 291], 'Ministry': [164], 'Health,': [166], 'Welfare': [167], 'Labor.': [169], 'The': [170], 'authors': [171], 'no': [173], 'other': [174], 'relevant': [175], 'affiliations': [176], 'financial': [178, 187, 191], 'involvement': [179], 'any': [181], 'organization': [182], 'entity': [184], 'interest': [188], 'conflict': [192], 'subject': [195], 'matter': [196], 'materials': [198], 'discussed': [199], 'manuscript': [202], 'apart': [203], 'those': [205], 'disclosed.No': [206], 'writing': [207], 'assistance': [208], 'utilized': [210], 'production': [213], 'this': [215], 'manuscript.Key': [216], 'issuesDaclatasvir': [217], 'first-in-class,': [220], 'replication': [222], 'complex': [223], 'pan-genotypic': [227], 'antiviral': [228, 422], 'activity': [229], 'vitro,': [231], 'once-daily': [233], 'dosing': [234], '1–100': [236], 'mg': [237], 'produced': [238], 'rapid': [240], 'substantial': [242], 'decrease': [243], '(HCV)-RNA': [248], 'levels': [249], 'chronically': [252], '1.Overall': [257], 'pegIFN': [261], 'plus': [264, 339], 'higher': [267], 'Asian': [269], 'studies': [270], 'than': [271], 'non-Asian': [273], 'studies.The': [274], 'combination': [277, 352, 397], 'treatment': [278, 418], 'showed': [283], 'rate': [290, 376, 404], '63.6': [292], '90.5%': [294], 'Phase': [297], 'II': [298], 'study': [299], 'Japan,': [301], 'but': [302, 349], 'most': [303, 345], 'NS5A-Y93H': [307], 'polymorphisms': [308], 'did': [309], 'not': [310, 355], 'emergence': [314], 'resistance': [316], 'mutations': [317], 'both': [319], 'protease': [325], 'observed.': [328], 'Preexisting': [329], 'viral': [330], 'evaluated.Dual': [335], 'therapy': [336, 353], 'twice-daily': [340], 'effective': [343, 356], 'Europe': [361], 'USA.': [364], 'When': [365], 'QUAD,': [372], 'reported': [378], 'as': [381, 383], '95%,': [384], 'subtype.Daclatasvir': [395], 'sofosbuvir': [399], 'provided': [400], 'an': [401], '12': [403], '98%.': [406], 'If': [407], 'resistant': [410], 'inhibitors,': [414], 'wait': [417], 'until': [419], 'drugs.Notes': [423]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2084076223', 'counts_by_year': [{'year': 2021, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 3}, {'year': 2018, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 4}], 'updated_date': '2024-12-12T21:14:34.974508', 'created_date': '2016-06-24'}